Oriola-KD and Meda have agreed on long-term cooperation in Sweden

Oriola-KD Corporation Stock Exchange release 2 May 2016 at 10.00 a.m.

Oriola-KD and Meda have agreed on long-term cooperation in Sweden

Oriola-KD Corporation's subsidiary Oriola and Meda, in Sweden, have signed a new long-term cooperation agreement on 29 April 2016. According to the cooperation agreement, Oriola-KD offers Meda pharmaceutical storage and distribution services in Sweden.

Meda, in Sweden, has its head office in Solna with over 80 employees. The product portfolio includes Rx and OTC pharmaceuticals as well as food supplements, medical devices and cosmetic products. The sales of Meda at wholesale prices were SEK 1121 million and market share in value was 3.2 percent in Sweden in 2015 (source: IMS Health).

Oriola-KD Corporation

Eero Hautaniemi
President and CEO

For further information, please contact:

Eero Hautaniemi
President and CEO
tel. +358 10 429 2109
eero.hautaniemi@oriola-kd.com

Distribution:
NASDAQ OMX Helsinki Ltd.
Key media

Released by:
Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo
www.oriola-kd.com




This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Oriola-KD Oyj via GlobeNewswire

HUG#2008848